It’s About Control, Not Exclusion: Why Trade Secrets Are Treated Like Property

Posted Leave a commentPosted in Asma Raza

“What is it about this exceptional right that should cause us to feel good calling it property? It is the component of control. Despite the fact that we can’t control whether somebody freely builds up a similar data, we can control who gains admittance to our own, and under what conditions.” Why the European Union […]

Google v. Oracle: An Expansive Fair Use Defense Deters Investment In Original Content

Posted Leave a commentPosted in Asma Raza

“On the off chance that the reasonable use safeguard is extended to incorporate what is generally viewed as business written falsification, there will be a chilling impact on trend-setters who bear the expense of unique substance advancement.” Google v. Prophet America, a case pending before the United States Supreme Court, is an apparently endless fight, […]

State Pharmaceutical Importation Programs Threaten Patients and Innovation

Posted Leave a commentPosted in Asma Raza

“The arrangement basically depends after bringing in value controls from Canada, which will both undermine advancement and demonstrate unsustainable.” “Given the quick development in the predominance of complex fake medications, no government official will affirm a medication importation plot without actualizing a sensible proportion of administrative oversight. There are essentially such a large number of […]